Literature DB >> 31737715

Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).

John Shumar1, Sarah Ordway2, Zachary Junga2, Brett Sadowski2, Dawn Torres2.   

Abstract

Presentations of drug-induced liver injury (DILI) are highly variable. Although biochemical evidence of cholestasis is common, the extent of aminotransferase elevations and patterns of liver injury vary. Patients may be asymptomatic, and many cases may never be diagnosed. We describe a case of memantine-induced hepatotoxicity in an elderly patient with Alzheimer's dementia, with probable causality for drug-induced liver injury, as assessed using the Roussel Uclaf Causality Assessment Method (RUCAM) score. Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.

Entities:  

Year:  2019        PMID: 31737715      PMCID: PMC6791641          DOI: 10.14309/crj.0000000000000184

Source DB:  PubMed          Journal:  ACG Case Rep J        ISSN: 2326-3253


  9 in total

1.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 2.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

3.  Memantine-induced hepatitis with cholestasis in a very elderly patient.

Authors:  Nicola Ferrara; Graziamaria Corbi; Annalisa Capuano; Amelia Filippelli; Francesco Rossi
Journal:  Ann Intern Med       Date:  2008-04-15       Impact factor: 25.391

4.  Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Authors:  George Ostapowicz; Robert J Fontana; Frank V Schiødt; Anne Larson; Timothy J Davern; Steven H B Han; Timothy M McCashland; A Obaid Shakil; J Eileen Hay; Linda Hynan; Jeffrey S Crippin; Andres T Blei; Grace Samuel; Joan Reisch; William M Lee
Journal:  Ann Intern Med       Date:  2002-12-17       Impact factor: 25.391

5.  ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.

Authors:  Naga P Chalasani; Paul H Hayashi; Herbert L Bonkovsky; Victor J Navarro; William M Lee; Robert J Fontana
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

6.  An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.

Authors:  T Craig Cheetham; Janet Lee; Christine M Hunt; Fang Niu; Steph Reisinger; Rich Murray; Greg Powell; Julie Papay
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-10-21       Impact factor: 2.890

Review 7.  Drug induced liver injury: accuracy of diagnosis in published reports.

Authors:  Rolf Teschke; Christian Frenzel; Albrecht Wolff; Axel Eickhoff; Johannes Schulze
Journal:  Ann Hepatol       Date:  2014 Mar-Apr       Impact factor: 2.400

Review 8.  Review article: drug hepatotoxicity.

Authors:  C Y Chang; T D Schiano
Journal:  Aliment Pharmacol Ther       Date:  2007-05-15       Impact factor: 8.171

Review 9.  RUCAM in Drug and Herb Induced Liver Injury: The Update.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.